Looking Past Aduhelm, Biogen Puts Pipeline On Display

Data Expected From Six Trials For Five Drugs Through 2022

Human brain drawn with string
Biogen highlighted neuroscience programs in Alzheimer's, ALS, depression and schizophrenia • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business